LITS vs TECH · $29.7M cap vs P/E 65, rev $1.22B
Lite Strategy, Inc. (LITS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Lite Strategy, Inc. (LITS) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported LITS revenue for 2025-06-30 was $0. Net income was -$15.9M. Revenue was down 100.0% from 2024-06-30 to 2025-06-30. LITS currently screens at market cap $29.7M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
LITS currently screens at market cap $29.7M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the LITS and TECH stock pages for the full models.
Not investment advice.